Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Representative Users Study Of Operating Characteristics Of The Caverject Delivery System.

NCT01008605 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01008605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01008605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Representative Users Study Of Operating Characteristics Of The Caverject Delivery System.
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2011
Completion date
February 28, 2011
Enrollment
48 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction